Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Price:
11.085
USD
2.64%
Market Closed
Market Cap:
$579.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
Gaumont SA
PAR:GAM
|
FR |
|
Washington H. Soul Pattinson and Company Ltd
ASX:SOL
|
AU |
|
Netcompany Group A/S
F:60N
|
DK |
Wall St Price Targets
FDMT Price Forecast
Based on 13 analysts
Based on 13 analysts
+158% Upside
from
$11.085
today
4D Molecular Therapeutics Inc (FDMT)’s 12-month stock price forecast through October 2027 has a consensus target of $28.56, implying 158% upside. The forecast is based on price targets from 13 Wall Street analysts.
FDMT Analyst Rating
Based on 12 analysts
Based on 12 analysts
Analysts rate FDMT Strong buy, with 11 of 12 recommending Buy or Strong buy.
4D Molecular Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FDMT's stock price target?
Price Target
28.56
USD
28.56
USD
According to Wall Street analysts, the average 1-year price target for FDMT is 28.56 USD with a low forecast of 18.18 USD and a high forecast of 38.85 USD.
What is the Revenue forecast for 4D Molecular Therapeutics Inc?
Projected CAGR
45%
45%
Over the last 7 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 8 years is 45%.